144 related articles for article (PubMed ID: 7675123)
1. Quinidine-induced potentiation of cardiovascular effects of nitrendipine: functional aspects and possible molecular mechanisms.
Herzig S; Jischa J; Beinhauer A; Geirhos B; Tacke K; Hempelmann RG
Naunyn Schmiedebergs Arch Pharmacol; 1995 Jun; 351(6):636-43. PubMed ID: 7675123
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of cardiodepressive action among calcium antagonists from different classes: evidence for a mechanism at the single calcium channel level.
Braun S; Frey N; Herzig S; Hilbert C
Naunyn Schmiedebergs Arch Pharmacol; 1992 May; 345(5):586-93. PubMed ID: 1326719
[TBL] [Abstract][Full Text] [Related]
3. Pattern of interaction between dihydropyridine calcium antagonists and cationic amphiphilic drugs in isolated guinea-pig left atria.
Schröder F; Herzig S
Arzneimittelforschung; 1993 Nov; 43(11):1148-51. PubMed ID: 8292056
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
5. Frequency- and potential-dependency of the negative inotropic action of various dihydropyridine and non-dihydropyridine calcium antagonists.
Herzig S; Lüllmann H; Sieg H
Pharmacol Toxicol; 1992 Sep; 71(3 Pt 1):229-35. PubMed ID: 1438049
[TBL] [Abstract][Full Text] [Related]
6. Effects of prolonged exposure to ethanol in vivo on functional parameters and sensitivity to nitrendipine in the isolated rat heart.
Guppy LJ; Littleton JM
J Cardiovasc Pharmacol; 1999 Sep; 34(3):414-9. PubMed ID: 10471001
[TBL] [Abstract][Full Text] [Related]
7. Dual effects of dihydropyridines on whole cell and unitary calcium currents in single ventricular cells of guinea-pig.
Brown AM; Kunze DL; Yatani A
J Physiol; 1986 Oct; 379():495-514. PubMed ID: 2435896
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
[TBL] [Abstract][Full Text] [Related]
9. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.
Hamilton SL; Yatani A; Brush K; Schwartz A; Brown AM
Mol Pharmacol; 1987 Mar; 31(3):221-31. PubMed ID: 2436031
[TBL] [Abstract][Full Text] [Related]
10. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
Ferry DR; Goll A; Glossmann H
Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective inhibition of thromboxane-induced coronary vasoconstriction by 1,4-dihydropyridine calcium channel antagonists.
Eltze M; Boer R; Sanders KH; Boss H; Ulrich WR; Flockerzi D
Chirality; 1990; 2(4):233-40. PubMed ID: 1964575
[TBL] [Abstract][Full Text] [Related]
12. Functional interaction between local anaesthetics and calcium antagonists in guineapig myocardium: 1. Cardiodepressant effects in isolated organs.
Herzig S; Ruhnke L; Wulf H
Br J Anaesth; 1994 Sep; 73(3):357-63. PubMed ID: 7946864
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive mechanism of action and binding sites of nitrendipine.
Triggle DJ
Am J Cardiol; 1986 Sep; 58(8):35D-38D. PubMed ID: 2429539
[TBL] [Abstract][Full Text] [Related]
14. Actions of 1,4-dihydropyridines in isolated mesenteric vascular beds.
Dhein S; Zhao Y; Simsek S; Salameh A; Klaus W
J Cardiovasc Pharmacol; 1995 Nov; 26(5):784-91. PubMed ID: 8637194
[TBL] [Abstract][Full Text] [Related]
15. Dihydropyridines inhibit acetylcholine-induced hyperpolarization in cochlear artery via blockade of intermediate-conductance calcium-activated potassium channels.
Jiang ZG; Shi XR; Guan BC; Zhao H; Yang YQ
J Pharmacol Exp Ther; 2007 Feb; 320(2):544-51. PubMed ID: 17082310
[TBL] [Abstract][Full Text] [Related]
16. PCA 50941, a novel Ca2+ channel agonist.
Priego J; González-Morales MA; Cillero FJ; Villarroya M; Sunkel C; de Casa-Juana MF; López MG; Artalejo CR; de Pascual R; García AG
Eur J Pharmacol; 1993 Oct; 243(1):25-34. PubMed ID: 7504630
[TBL] [Abstract][Full Text] [Related]
17. Effect of S-312, a new calcium channel blocker, on the 1,4-dihydropyridine binding sites in porcine basilar blood vessels and rat aortic smooth muscle cells.
Mihara S; Fujimoto M
Jpn J Pharmacol; 1991 Jul; 56(3):249-59. PubMed ID: 1832726
[TBL] [Abstract][Full Text] [Related]
18. Functional interaction between benzothiazepine- and dihydropyridine binding sites of cardiac L-type Ca2+ channels.
Kanda S; Adachi-Akahane S; Nagao T
Eur J Pharmacol; 1998 Oct; 358(3):277-87. PubMed ID: 9822895
[TBL] [Abstract][Full Text] [Related]
19. MPC-1304, another type of dihydropyridine, possessing highly potent vasodilating action.
Miyoshi K; Kanda A; Miyake H; Ichihara K; Kamei H; Nagasaka M
Eur J Pharmacol; 1993 Jul; 238(2-3):139-48. PubMed ID: 7691619
[TBL] [Abstract][Full Text] [Related]
20. Chronic dihydropyridine treatment can reverse the behavioural consequences of and prevent adaptations to, chronic ethanol treatment.
Whittington MA; Dolin SJ; Patch TL; Siarey RJ; Butterworth AR; Little HJ
Br J Pharmacol; 1991 Jul; 103(3):1669-76. PubMed ID: 1834295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
